Clinical data | |
---|---|
Trade names | Eprinex |
Other names | MK-397, 4"-epi-acetylamino-4"-deoxy-avermectin B1a (4"R)-4"-(acetylamino)-5-O-demethyl-4"-deoxyavermectin A1a |
License data |
|
Routes of administration | Topical |
ATCvet code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 29%[2] |
Protein binding | >99%[2] |
Onset of action | 24 hours[2] |
Elimination half-life | 8–36 days[2] |
Duration of action | 7–10 days[2] |
Excretion | Feces (17–19.8%), urine (0.35%), milk (0.32–0.54%)[2] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C50H75NO14 |
Molar mass | 914.143 g·mol−1 |
3D model (JSmol) | |
| |
|
Clinical data | |
---|---|
Other names | 4"-epi-acetylamino-4"-deoxy-avermectin B1b |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C49H73NO14 |
Molar mass | 900.116 g·mol−1 |
3D model (JSmol) | |
| |
|
Eprinomectin is an avermectin used as a veterinary topical endectocide.[1][3] It is a mixture of two chemical compounds, eprinomectin B1a and B1b.[4]